Evaluation of Safety and Dosimetry of 177Lu-DOTA-ZOL for Therapy of Bone Metastases.

Saved in:

Bibliographic Details
Title:	Evaluation of Safety and Dosimetry of ¹⁷⁷Lu-DOTA-ZOL for Therapy of Bone Metastases.
Authors:	Fernández R; Center for Nuclear Medicine and PET/CT, PositronMed, Santiago, Chile., Eppard E; Positronpharma SA, Santiago, Chile; eeppard@positronpharma.cl., Lehnert W; ABX-CRO, Dresden, Germany.; Department of Nuclear Medicine, University Medical Center, Hamburg, Germany., Jiménez-Franco LD; ABX-CRO, Dresden, Germany., Soza-Ried C; Center for Nuclear Medicine and PET/CT, PositronMed, Santiago, Chile., Ceballos M; Center for Nuclear Medicine and PET/CT, PositronMed, Santiago, Chile., Ribbeck J; Positronpharma SA, Santiago, Chile., Kluge A; ABX-CRO, Dresden, Germany., Rösch F; Institute of Nuclear Chemistry, Johannes Gutenberg-University, Mainz, Germany; and., Meckel M; Isotope Technologies Garching GmbH, Munich, Germany., Zhernosekov K; Isotope Technologies Garching GmbH, Munich, Germany., Kramer V; Center for Nuclear Medicine and PET/CT, PositronMed, Santiago, Chile.; Positronpharma SA, Santiago, Chile., Amaral H; Center for Nuclear Medicine and PET/CT, PositronMed, Santiago, Chile.; Positronpharma SA, Santiago, Chile.
Source:	Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2021 Aug 01; Vol. 62 (8), pp. 1126-1132. Date of Electronic Publication: 2021 Jan 08.
Publication Type:	Journal Article; Clinical Trial
Journal Info:	Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med
Database:	MEDLINE Ultimate

Description
ISSN:	1535-5667
DOI:	10.2967/jnumed.120.255851